We are live on ! Find out more
VP

venBio Partners Portfolio holdings

AUM $281M
1-Year Est. Return 261.03%
This Fund
S&P 500
This Quarter Est. Return
+51.26%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
AUM
$281M
AUM Growth
+$64.3M
Cap. Flow
+$3.2M
Cap. Flow %
1.14%
Top 10 Hldgs %
100%
Holding
6
New
Increased
1
Reduced
2
Closed

Top Buys

1
ALXO icon
ALX Oncology
ALXO
+$6.07M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHVS icon
1
Pharvaris
PHVS
$2.46B
$131M 46.72%
4,639,304
ALMS
2
Alumis Inc
ALMS
$3.67B
$99.8M 35.56%
4,528,408
-91,395
-2% -$2.28M
ALXO icon
3
ALX Oncology
ALXO
$273M
$25.8M 9.21%
12,884,638
+3,184,713
+33% +$6.07M
HRMY icon
4
Harmony Biosciences
HRMY
$2.02B
$13.7M 4.88%
489,194
LYEL icon
5
Lyell Immunopharma
LYEL
$349M
$6.77M 2.41%
337,697
ARTV
6
Artiva Biotherapeutics
ARTV
$482M
$3.42M 1.22%
531,337
-117,170
-18% -$580K

Similar funds